首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Therapeutic advances in psychopharmacology

缩写:

ISSN:2045-1253

e-ISSN:2045-1261

IF/分区:5.0/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引614
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Mark Abie Horowitz,Adele Framer,John Strang et al. Mark Abie Horowitz et al.
Formal guidelines recommend that opioids should be stopped when risks outweigh benefits. These guidelines generally recommend gradual dose tapering at a rate tolerable to the patient. However, there is considerable variation regarding the p...
Candice E Crocker,Thomas Hastings,Marc-Andre Roy et al. Candice E Crocker et al.
Background: Patients treated in early intervention for psychosis programs have better treatment outcomes and higher rates of long-acting injection (LAI) antipsychotic medication utilization (20%-50%) versus treatment as u...
Stanley Wong,Brett D M Jones,Mathura T Thiyagarajah et al. Stanley Wong et al.
Background: Results from contemporary clinical trials of serotonergic psychedelic therapies have led to an increasing focus on their potential clinical use across mental disorders. However, studies examining mechanisms of...
Luke Flynn,Martin Krsak,Mary Rondeau et al. Luke Flynn et al.
Background: Job-related stress and its extreme form, burnout, continue to affect almost half of all frontline healthcare workers and first responders. Current treatments are inadequate. ...
Hasan Çağın Lenk,Line Skute Bråten,Ole A Andreassen et al. Hasan Çağın Lenk et al.
Background: Clozapine is the most effective drug for schizophrenia and is the only drug indicated for use in patients with treatment resistance. The therapeutic range of clozapine is narrow with extensive interindividual ...
Sally Meikle,Olivia Carter,Paul Liknaitzky et al. Sally Meikle et al.
Background: Depressive disorders are a major global health challenge, with many individuals unresponsive to existing treatments. Novel psychedelic therapies show promise but require further research. ...
S D Muthumaraswamy,M J Baggott,E E Schenberg et al. S D Muthumaraswamy et al.
Psychedelic-assisted therapy (PAT) has typically been evaluated using conventional randomised controlled trials (RCTs), which assess treatment efficacy under highly controlled conditions. However, PAT constitutes a complex intervention, int...
Chengchuan Chen,Na Zhou,Jixin Hou Chengchuan Chen
Background: Postoperative delirium (POD) is associated with higher risks of postoperative complications ‌and‌ mortality (2- to 3-fold increase). Studies investigating the effect of intraoperative ketamine on POD risk ha...
Claudio Brasso,Anna Maria Beoni,Gianluca Colli et al. Claudio Brasso et al.
Background: Poor adherence to antipsychotic medications is the leading cause of relapses and hospitalizations in patients with schizophrenia, resulting in worse functional outcomes and quality of life. Long-acting injecta...